Table 7.
Comparison of follow-up results between COPD and BCOS groups
| Items | Total | COPD | BCOS | P-value |
|---|---|---|---|---|
| One year follow-up, n |
875 |
704 |
171 |
|
|
Death, n (%)
|
58 (6.6) |
46 (6.5) |
12 (7.0) |
0.837 |
|
Times of severe exacerbations in the past 12 mo, MD (IQR)
|
1 (0–2) |
1 (0–2) |
1 (0–2) |
0.539 |
| Two years follow-up, n |
786 |
654 |
132 |
|
|
Death, n (%)
|
108 (13.7) |
88 (13.5) |
20 (15.2) |
0.622 |
|
Times of severe exacerbations in the past 12 mo, MD (IQR)
|
1 (0–2) |
1 (0–2) |
1 (0–2) |
0.582 |
| Three years follow-up, n |
654 |
558 |
96 |
|
|
Death, n (%)
|
233 (35.6) |
201 (36.0) |
32 (33.3) |
0.944 |
| Times of severe exacerbations in the past 12 mo, MD (IQR) | 1 (0–2) | 1 (0–2) | 1 (0–2) | 0.890 |
BCOS – bronchiectasis- chronic obstructive pulmonary disease overlap syndrome, COPD – chronic obstructive pulmonary disease, MD – median, IQR – interquartile range